Literature DB >> 12067981

Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.

Howard F Tiano1, Charles D Loftin, Jackie Akunda, Christopher A Lee, Judson Spalding, Alisha Sessoms, David B Dunson, Eleanor G Rogan, Scott G Morham, Robert C Smart, Robert Langenbach.   

Abstract

Nonsteroidal anti-inflammatory drugs are widely reported to inhibit carcinogenesis in humans and in rodents. These drugs are believed to act by inhibiting one or both of the known isoforms of cyclooxygenase (COX). However, COX-2, and not COX-1, is the isoform most frequently reported to have a key role in tumor development. Here we report that homozygous deficiency of either COX-1 or COX-2 reduces skin tumorigenesis by 75% in a multistage mouse skin model. Reduced tumorigenesis was observed even though the levels of stable 7,12-dimethylbenz(a)anthracene-DNA adducts were increased about 2-fold in the COX-deficient mice compared with wild-type mice. The premature onset of keratinocyte terminal differentiation appeared to be the cellular event leading to the reduced tumorigenesis because keratin 1 and keratin 10, two keratins that indicate the commitment of keratinocytes to differentiate, were expressed 8-13-fold and 10-20-fold more frequently in epidermal basal cells of the COX-1-deficient and COX-2-deficient mice, respectively, than in wild-type mice. Papillomas on the COX-deficient mice also displayed the premature onset of keratinocyte terminal differentiation. However, loricrin, a late marker of epidermal differentiation, was not significantly altered, suggesting that it was the early stages of keratinocyte differentiation that were primarily affected by COX deficiency. Because keratin 5, a keratin associated with basal cells, was detected differently in papillomas of COX-1-deficient as compared with COX-2-deficient mice, it appears that the isoforms do not have identical roles in papilloma development. Interestingly, apoptosis, a cellular process associated with nonsteroidal anti-inflammatory drug-induced inhibition of tumorigenesis, was not significantly altered in the epidermis or in papillomas of the COX-deficient mice. Thus, both COX-1 and COX-2 have roles in keratinocyte differentiation, and we propose that the absence of either isoform causes premature terminal differentiation of initiated keratinocytes and reduced tumor formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067981

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  100 in total

Review 1.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

2.  UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.

Authors:  Benjamin L Judson; Akira Miyaki; Vikram D Kekatpure; Baoheng Du; Patricia Gilleaudeau; Mary Sullivan-Whalen; Arash Mohebati; Sudhir Nair; Jay O Boyle; Richard D Granstein; Kotha Subbaramaiah; James G Krueger; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-19

3.  Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition.

Authors:  Xin Tong; Rukiyah T Van Dross; Adnan Abu-Yousif; Aubrey R Morrison; Jill C Pelling
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

4.  Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2.

Authors:  Louise Y Y Fong; Yubao Jiang; Maurisa Riley; Xianglan Liu; Karl J Smalley; Denis C Guttridge; John L Farber
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

5.  Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis.

Authors:  Yasuhiro Matsumura; Angus M Moodycliffe; Dat X Nghiem; Stephen E Ullrich; Honnavara N Ananthaswamy
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Inhibition of phorbol ester-induced mouse skin tumor promotion and COX-2 expression by celecoxib: C/EBP as a potential molecular target.

Authors:  Kyung-Soo Chun; Joydeb Kumar Kundu; Kwang-Kyun Park; Won-Yoon Chung; Young-Joon Surh
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

7.  Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.

Authors:  Kausar M Ansari; Joyce E Rundhaug; Susan M Fischer
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

8.  Cell-type-specific roles for COX-2 in UVB-induced skin cancer.

Authors:  Jing Jiao; Carol Mikulec; Tomo-o Ishikawa; Clara Magyar; Darren S Dumlao; Edward A Dennis; Susan M Fischer; Harvey Herschman
Journal:  Carcinogenesis       Date:  2014-01-27       Impact factor: 4.944

9.  Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.

Authors:  Karin Muller-Decker; Gitta Neufang; Irina Berger; Melanie Neumann; Friedrich Marks; Gerhard Furstenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

10.  Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation.

Authors:  Huei-Chen Lao; Jacqueline K Akunda; Kyung-Soo Chun; Gordon P Flake; Stuart H Yuspa; Robert Langenbach
Journal:  Carcinogenesis       Date:  2012-08-17       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.